# CDER Division of Applied Regulatory Science’s (DARS) Purchase of Cryopreservation System

Canonical: https://abierto.us/opportunities/75f40124q00543

- Solicitation number: 75F40124Q00543
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was September 18, 2024 at 2:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 333415 Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing
- Product or service code: 4110 Refrigeration Equipment
- Set-aside: Total small business set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: September 12, 2024
- Last posted: September 12, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/0cba3dba5e0a41b899a95388c667ea58/view

## Description

The objective of this project is the purchase of an additional high-performance cryopreservation freezer to complement our older existing MVE freezers thereby enhancing overall cryogenic storage capacity while reducing downtime caused by maintenance issues with older freezers. The new cryogenic freezer must be compatibility with our older existing cryogenic MVE Biological Solutions (MVE) systems in terms of storage conditions in order to minimize study to study variations.

The high-performance cryopreservation characteristics of MVE systems will provide multiple benefits over conventional systems including but not limited to holding temperatures stable from top to bottom of vacuum vessel sealing cork top for near 100% enclosure, keeping the samples and liquid nitrogen separate and ease of access so maintenance can be performed without moving samples.

The new system’s benefits will ensure that samples collected from projects in DARS including drug metabolism, invitro drug testing, pharmacokinetic, pharmacodynamic and toxicology studies are stored safely and that storage conditions are identical between the new and existing cryogenic freezers.

## Publications

- September 12, 2024: Combined synopsis and solicitation, due September 18, 2024 at 2:00 PM EDT. Notice 0cba3dba5e0a41b899a95388c667ea58. https://sam.gov/workspace/contract/opp/0cba3dba5e0a41b899a95388c667ea58/view

## Points of contact

- Nicholas Bisher, Nicholas.Bisher@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124q00543.